Belgravia Hartford Capital Inc. Provides Corporate Update
Belgravia Hartford Capital Inc. (CSE: BLGV) has announced two key appointments to strengthen its leadership team. Ms. Ava Tahmasebi, a seasoned executive with over a decade of experience in the startup ecosystem, has been appointed as an independent director to the Board. She holds a Ph.D. in Wireless Networks and is the CEO of Startup Station, a Toronto-based startup studio focusing on women entrepreneurs.
Dr. Shoaib Sheikh, MD, FACS, has been appointed as head of the company's advisory committee. Dr. Sheikh is a surgeon with extensive experience serving on multiple boards and committees. He also owns 12.49% of Belgravia Hartford's outstanding common shares.
These appointments aim to enhance governance, provide fresh perspectives on investments, and bring global business experience to the company. The CEO, Mehdi Azodi, expressed that these additions will support the company's due diligence process and help build a new business platform while funding litigation affairs.
Belgravia Hartford Capital Inc. (CSE: BLGV) ha annunciato due nomine chiave per rafforzare il suo team di leadership. La signora Ava Tahmasebi, un'esperta esecutiva con oltre un decennio di esperienza nell'ecosistema startup, è stata nominata come direttrice indipendente del Consiglio. Possiede un dottorato in Reti Wireless ed è l'amministratore delegato di Startup Station, uno studio di startup con sede a Toronto focalizzato sulle imprenditrici.
Il dott. Shoaib Sheikh, MD, FACS, è stato nominato capo del comitato consultivo dell'azienda. Il dott. Sheikh è un chirurgo con vasta esperienza in diversi consigli e comitati. Possiede inoltre il 12,49% delle azioni ordinarie in circolazione di Belgravia Hartford.
Queste nomine mirano a migliorare la governance, fornire nuove prospettive sugli investimenti e portare esperienza commerciale globale all'azienda. L'amministratore delegato, Mehdi Azodi, ha espresso che queste aggiunte sosterranno il processo di due diligence dell'azienda e contribuiranno a creare una nuova piattaforma commerciale mentre si finanziano le controversie legali.
Belgravia Hartford Capital Inc. (CSE: BLGV) ha anunciado dos nombramientos clave para fortalecer su equipo de liderazgo. La Sra. Ava Tahmasebi, una ejecutiva experimentada con más de una década de experiencia en el ecosistema de startups, ha sido nombrada directora independiente de la Junta. Ella posee un doctorado en Redes Inalámbricas y es la CEO de Startup Station, un estudio de startups con sede en Toronto que se centra en las emprendedoras.
El Dr. Shoaib Sheikh, MD, FACS, ha sido nombrado como jefe del comité asesor de la empresa. El Dr. Sheikh es un cirujano con amplia experiencia en múltiples juntas y comités. También posee el 12.49% de las acciones ordinarias en circulación de Belgravia Hartford.
Estos nombramientos tienen como objetivo mejorar la gobernanza, proporcionar nuevas perspectivas sobre inversiones y aportar experiencia empresarial global a la empresa. El CEO, Mehdi Azodi, expresó que estas adiciones apoyarán el proceso de debida diligencia de la empresa y ayudarán a construir una nueva plataforma de negocios mientras financian los litigios.
벨그라비아 하트포드 캐피탈 주식회사 (CSE: BLGV)는 리더십 팀을 강화하기 위해 두 가지 주요 임명을 발표했습니다. 아바 타마세비 씨는 스타트업 생태계에서 10년 이상의 경험을 가진 베테랑 경영자이며, 이사회에 독립 이사로 임명되었습니다. 그녀는 무선 네트워크 박사 학위를 보유하고 있으며, 여성 기업가에 초점을 맞춘 토론토 기반 스타트업 스튜디오인 스타트업 스테이션의 CEO입니다.
쇼에이프 셰이크 박사는 이 회사의 자문 위원회 의장으로 임명되었습니다. 셰이크 박사는 여러 이사회 및 위원회에서의 폭넓은 경험을 가진 외과 의사입니다. 또한, 벨그라비아 하트포드의 발행된 보통주 12.49%를 소유하고 있습니다.
이러한 임명은 거버넌스를 강화하고 투자에 대한 새로운 관점을 제공하며, 회사에 글로벌 비즈니스 경험을 가져오는 것을 목표로 합니다. CEO 메흐디 아조디는 이러한 추가 인력들이 회사의 실사 과정에 도움을 주고 새로운 비즈니스 플랫폼을 구축하며 법적 문제의 자금을 지원하는 데 기여할 것이라고 밝혔습니다.
Belgravia Hartford Capital Inc. (CSE: BLGV) a annoncé deux nominations clés pour renforcer son équipe de direction. Mme Ava Tahmasebi, une dirigeante chevronnée avec plus d'une décennie d'expérience dans l'écosystème des startups, a été nommée administratrice indépendante du conseil d'administration. Elle détient un doctorat en réseaux sans fil et est la directrice générale de Startup Station, un studio de startups basé à Toronto axé sur les entrepreneuses.
Dr. Shoaib Sheikh, MD, FACS, a été nommé responsable du comité consultatif de l'entreprise. Dr. Sheikh est un chirurgien possédant une vaste expérience au sein de plusieurs conseils et comités. Il possède également 12,49 % des actions ordinaires en circulation de Belgravia Hartford.
Ces nominations visent à améliorer la gouvernance, à fournir de nouvelles perspectives sur les investissements et à apporter une expérience commerciale mondiale à l'entreprise. Le CEO, Mehdi Azodi, a exprimé que ces ajouts soutiendront le processus de diligence raisonnable de l'entreprise et aideront à construire une nouvelle plateforme commerciale tout en finançant des affaires judiciaires.
Belgravia Hartford Capital Inc. (CSE: BLGV) hat zwei Schlüsselberufungen bekannt gegeben, um sein Führungsteam zu stärken. Frau Ava Tahmasebi, eine erfahrene Führungskraft mit über einem Jahrzehnt Erfahrung im Startup-Ökosystem, wurde als unabhängige Direktorin in den Vorstand berufen. Sie hat einen Doktortitel in Wireless Networks und ist die CEO von Startup Station, einem in Toronto ansässigen Startup-Studio, das sich auf weibliche Unternehmerinnen konzentriert.
Dr. Shoaib Sheikh, MD, FACS, wurde zum Leiter des Beratungsausschusses des Unternehmens ernannt. Dr. Sheikh ist ein Chirurg mit umfangreicher Erfahrung in verschiedenen Gremien und Ausschüssen. Er besitzt auch 12,49 % der ausgegebenen Stammaktien von Belgravia Hartford.
Diese Ernennungen zielen darauf ab, die Unternehmensführung zu verbessern, neue Perspektiven zu Investitionen zu bieten und globale Geschäftserfahrung ins Unternehmen zu bringen. Der CEO, Mehdi Azodi, äußerte, dass diese Ergänzungen den Due-Diligence-Prozess des Unternehmens unterstützen und dazu beitragen werden, eine neue Geschäftsplattform aufzubauen, während gleichzeitig rechtliche Angelegenheiten finanziert werden.
- Appointment of experienced independent director Ms. Ava Tahmasebi to the Board
- Dr. Shoaib Sheikh appointed as head of the advisory committee, bringing extensive board experience
- Dr. Sheikh owns 12.49% of the company's outstanding common shares, indicating significant insider investment
- None.
Toronto, Ontario--(Newsfile Corp. - August 15, 2024) - BELGRAVIA HARTFORD CAPITAL INC. (CSE: BLGV) ("Belgravia Hartford", "Belgravia" or the "Company") is pleased to announce the appointment of Ms. Ava Tahmasebi as an independent director to the Board of the Company. Additionally, Dr. Shoaib Sheikh has been appointed as head of the company's advisory committee.
Ms. Ava Tahmasebi is a seasoned executive with over a decade of experience in driving innovation and business growth within the startup ecosystem. She holds a Doctor of Philosophy (Ph.D.) in Wireless Networks and has recently updated her skills through a Data Analytics program at the University of Toronto. Ms. Tahmasebi has played a pivotal role in mentoring over 50 startups, steering them towards notable success. As CEO of Startup Station, a Toronto-based startup studio with a focus on women entrepreneurs, she has refined her expertise in transforming nascent ideas into successful, market-ready businesses. Startup Station is a member of the National Angel Capital Organization (NACO).
Dr. Shoaib Sheikh, MD, FACS, is a surgeon who has served on multiple provincial, national and international boards and committees for the past 17 years. The nature of involvement has been from board of directors, executive committees, editorial boards and provincial review committees. Dr. Sheikh has served for two full terms on the Board of Governors of the American College of Surgeons which has 90,000 member surgeons and has served on the finance committee of the College of Surgeons. Dr. Shiekh also owns 8,414,095 common shares of Belgravia Hartford which represents
Mr. Mehdi Azodi, The CEO & President of Belgravia stated "The addition of Ms. Tahmasebi to the board strengthens the governance and adds fresh perspective on future investments and due diligence process. The appointment of Dr. Sheikh provides the board and legal team with global business experience and access to capital injection for the company to build out a new business platform and fund the company's litigation affairs."
About Belgravia Hartford
Belgravia Hartford Capital Inc. ("Belgravia" or the "Company") is a publicly traded investment holding company listed on the Canadian Securities Exchange. Belgravia is focused on growing its assets and holdings and increasing its net asset value (NAV). Belgravia invests in a portfolio of private and public companies located in jurisdictions governed by the rule of law. It takes a multi-sector investment approach with emphasis in the resources and commodities sector. Belgravia and its investments are considered high risk holdings and it may expose shareholders to significant volatility and losses.
For more information, please visit www.belgraviahartford.com
Forward-Looking Statements
Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements include statements that use forward-looking terminology such as "may", "will", "expect", "anticipate", "believe", "continue", "potential" or the negative thereof or other variations thereof or comparable terminology. Such forward-looking statements include, without limitation, statements regarding planned investment activities & related returns, the timing for completion of research and development activities, the potential value of royalties, and other statements that are not historical facts. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including, but not limited to, changes in market trends, the completion, results and timing of research undertaken by the Company, risks associated with resource assets, the impact of general economic conditions, commodity prices, industry conditions, dependence upon regulatory, environmental, and governmental approvals, and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.
For More Information, Please Contact:
Mehdi Azodi, President & CEO
Belgravia Hartford Capital Inc.
(416) 779-3268
mazodi@blgv.ca
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/220043
FAQ
Who are the new appointees to Belgravia Hartford Capital Inc. (BLGVF) leadership team?
What is Ms. Ava Tahmasebi's background and role at Belgravia Hartford Capital Inc. (BLGVF)?
How many shares of Belgravia Hartford Capital Inc. (BLGVF) does Dr. Shoaib Sheikh own?
What are the expected benefits of these new appointments for Belgravia Hartford Capital Inc. (BLGVF)?
